(All fields required)
Please enter a valid email.
Please enter your name.
Julia S. Anixt, MD Pediatrician, Developmental and Behavioral Pediatrics
Pediatrician, Developmental and Behavioral Pediatrics
Assistant Professor, UC Department of Pediatrics
Attention Deficit / Hyperactivity Disorder (ADHD); Autism Spectrum Disorders (ASD); learning difficulties; developmental and behavioral issues in underserved populations; developmental outcomes in children with congenital heart disease
ADHD; use of shared decision making for the treatment of challenging behavior in children with ASD; the diagnosis and management of behavioral and mental health issues in primary care settings; access to care for underserved populations
Julia Anixt, MD, is a developmental-behavioral pediatrician conducting clinical research on Attention Deficit/ Hyperactivity Disorder (ADHD). In particular her work focuses on improving the quality of care for ADHD diagnosis and treatment for children in underserved communities and assessing the impact of parent and youth perceptions about ADHD on treatment decisions. Her research also focuses on implementing Shared Decision Making (SDM) in the clinical setting for families of children with Autism Spectrum Disorders (ASD) contemplating the use of medication to target challenging behaviors.
Anixt JS, Copeland-Linder N, Haynie D, Cheng TL. Burden of Unmet Mental Health Needs in Assault-Injured Youths Presenting to the Emergency Department. Academic Pediatrics. 2012; 12(2): 125-30.
Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC. Update on Environmental Risk Factors for Attention-Deficit/Hyperactivity Disorder. Current Psychiatry Reports. 2011; 13(5): 333-44.
Olaniyan O, dosReis S, Garriett V, Mychailyszyn MP, Anixt J, Rowe PC, Cheng TL. Community Perspectives of Childhood Behavioral Problems and ADHD among African-American Parents. Ambulatory Pediatrics. 2007; 7(3): 226-231. dosReis S, Butz A, Lipkin PH, Anixt JS, Weiner CL, Chernoff R. Attitudes About Stimulant Medication for Attention-Deficit/Hyperactivity Disorder Among African American Families in an Inner City Community. The Journal of Behavioral Health Services Research. 2006;33(4): 423-430.
Holly D. Barnard, PhD Neuropsychologist, Division of Developmental and Behavioral Pediatrics
is a neuropsychologist whose research efforts have focused on neuropsychological sequelae of neurodevelopmental disorders and the interplay of genes and the environment in the manifestation of symptoms. Dr. Barnard is currently focused on projects exploring social interactions of children with ASDs and the impact of environmental risk factors (e.g., maternal cotinine levels) on the manifestation of executive dysfunction.
Neuropsychologist, Division of Developmental and Behavioral Pediatrics
Pediatric neuropsychology; autism spectrum disorders
Dr. Barnard completed her PhD in clinical psychology at the University of Denver, where she was awarded a National Research Service Awards (NRSA) from the National Institute of Mental Health (NIMH) to study gene-environment interactions in the manifestation of Attention-Deficit Hyperactivity Disorder (ADHD). She went on to complete her internship and APPCN fellowship in pediatric neuropsychology at the University of Illinois at Chicago Medical Center (UICMC), where she received broad-based training in both medical and developmental neuropsychology in children and pursued specialty training (site reliability in the administration and coding of the ADOS and ADI-R) in diagnostic assessment of Autism Spectrum Disorders (ASDs).
Since being recruited to Cincinnati Children's, Dr. Barnard has co-founded the Developmental Neuropsychology Clinic (DNC), a doctoral-level practicum placement in pediatric neuropsychology, and currently supervises advanced doctoral students hailing from numerous programs around the Tristate area. Dr. Barnard and her team in the DNC evaluate patients who present with a wide variety of neurodevelopmental conditions, but Dr. Barnard continues to have a particular interest in ASDs and genetic/chromosomal disorders. Additionally, Dr. Barnard consults on numerous ongoing research projects, both through Cincinnati Children's and University of Cincinnati (UC), and serves as an active instructor in the doctoral program at UC.
BA: Neuroscience, Amherst College, Amherst, MA, 2001.
PhD: Clinical Psychology, University of Denver, Denver, CO, 2009.
Internship: Child Psychology, Institute for Juvenile Research; University of Illinois at Chicago Medical Center, Chicago, IL.
Fellowship: Pediatric Neuropsychology, University of Illinois at Chicago Medical Center, Chicago, IL.
McGrath LM, Pennington BF, Shanahan MA, Santerre-Lemmon LE, Barnard HD, Willcutt EG, Olson RK, DeFries JC. A Multiple Deficit Model of Reading Disability and Attention-Deficit/Hyperactivity Disorder: Processing Speed is a Shared Cognitive Deficit. Journal of Child Psychiatry and Psychology. 2011;52:547-57.
Betjemann RS, Johnson EP, Barnard HD, Boada R, Filley CM, Filipek PA, Willcutt EG, DeFries JC, Pennington BF. Genetic Covariation Between Brain Volumes and IQ, Reading Performance, and Processing Speed. Behavior Genetics. 2010;40:135-145.
Pennington BF, McGrath LM, Rosenberg JL, Barnard HD, Smith SD, Willcutt EW, Friend A, Olson RK. Gene X Environment Interactions in Reading Disability and Attention-Deficit/Hyperactivity Disorder. Development and Psychopathology. 2009;45:77-89.
Allen G, Barnard HD, McColl R, Hester A, Fields J, Weiner MF, Ringe WK, Lipton AM, Brooker M, McDonald E, Rubin CD, Cullum CM. Reduced Hippocampal Functional Connectivity in Alzheimer’s Disease. Archives of Neurology. 2007;64:1482-1487.
Allen G, McColl RW, Barnard HD, Ringe WK, Fleckenstein J, Cullum CM. Magnetic Resonance Imaging of Cerebellar-Prefrontal and Cerebellar-Parietal Functional Connectivity. NeuroImage. 2005;28:39-48.
Chandler MJ, Lacritz LH, Hynan LS, Barnard HD, Allen G, Deschner M, Weiner MF, Cullum CM. A Total Score for the CERAD Neuropsychological Battery. Neurology. 2005;65:102-106.
Lacritz LH, Barnard HD, Van Ness P, Agostini M, Diaz-Arrastia R, Cullum CM. Qualitative analysis of the WMS-III Logical Memory and Visual Reproduction in Temporal Lobe Epilepsy. Journal of Clinical and Experimental Neuropsychology. 2004;26:521-530.
Amie W. Duncan, PhD
is a clinical psychologist who researches the transition to adulthood in adolescents with autism spectrum disorders (ASD). Specifically, she is interested in identifying factors that may promote or impede an optimal outcome in adulthood for individuals with ASD. She is also developing an intervention to increase daily living skills and overall independence in adolescents with ASD.
Autism spectrum disorders; transition to adulthood in adolescents with autism
BS: University of Dayton, 2004.
MA: University of Alabama, Tuscaloosa, AL, 2006.PhD: University of Alabama, 2009.
Huerta M, Bishop S, Duncan AW, Hus V, Lord C. Application of DSM-5 criteria for autism spectrum disorder to three samples of children with DSM-IV diagnoses of pervasive developmental disorders. Am J Psychiatry. 2012;169:1056-1064.
Duncan AW, Klinger LG. Building social skills: Working with adolescents with ASD in clinics, schools, and the community. Social Work with Groups. 2010;33:175-193.
Scofield J, Williams A. Word learning in the absence of a speaker: Applications of the principles of mutual exclusivity and taxonomy. First Language. 2009;29, 277-289.
Klinger LG, Williams A. Cognitive behavioral interventions for students with Asperger’s syndrome and high functioning autism. In MJ Mayer, R Van Acker, JE Lochman, FM Gresham (Eds). Cognitive Behavioral Interventions for Students with Emotional/Behavioral Disorders. New York: Guilford. 2008.
Scofield J, Williams A, Behrend D. Word learning in the absence of a speaker. First Language. 2007;27, 297-311.
Anna J. Esbensen, PhD
Behavior management; depression
Lifespan development of down syndrome; health care of individuals with down syndrome; development of depressive symptomatology among individuals with intellectual disability
Anna Esbensen is an assistant professor of psychology in the Division of Developmental and Behavioral Pediatrics. She studies the lifespan development of individuals with Down syndrome and provides clinical services through the Thomas Center. She also studies the mental health of individuals with intellectual disability.
Tanya Elizabeth Froehlich, MD, MS, FAAP
focuses on attention-deficit/hyperactivity disorder. She is working to identify genetic and phenotypic predictors of ADHD medication response, as well as studying the contribution of environmental exposures (e.g., lead, tobacco, and pesticides) to ADHD etiology. In addition, her prior publications and current projects investigate the prevalence of ADHD, ADHD medication use, and preschool psychotropic medication use.
Associate Professor, UC Department of Pediatrics
Dr. Froehlich is a developmental-behavioral pediatrician who cares for school age children with learning and behavioral issues. Her research has a special focus on attention-deficit/hyperactivity disorder (ADHD), and approaches the disorder from the vantage points of epidemiology, etiology, and treatment. She conducted a study reporting the national prevalence of ADHD in U.S. children based on DSM-IV criteria (published in the Archives of Pediatrics and Adolescent Medicine) which showed that children from disadvantaged socioeconomic backgrounds were most likely to meet criteria for ADHD, yet least likely to receive consistent ADHD pharmacotherapy. Interested in understanding why certain children (including those with low socioeconomic status) may be more vulnerable to ADHD than others, she also studies the contribution of environmental exposures to ADHD and their public health impact. In Pediatrics, she published the first study to investigate the interactive effects of prenatal tobacco exposure and childhood lead exposure on ADHD and demonstrated that the association between poverty and ADHD is partially explained by the effects of these common environmental toxicants. She has also examined possible gene-environment interactions and found that boys with specific dopamine-related genetic variants were particularly susceptible to the adverse effects of lead exposure on ADHD-related executive functioning (published in Biological Psychiatry). Dr. Froehlich continues to research environmental influences on ADHD as a co-investigator on a National Institute of Environmental Health Sciences R01 grant which is examining the effects of pyrethroid pesticide exposure on ADHD symptoms and executive functioning.
Dr. Froehlich’s research agenda also addresses ADHD treatment. She is the recipient of a National Institute of Mental Health K23 Award aimed at identifying genetic and phenotypic predictors of ADHD medication response. Recently, she authored a paper in the Journal of the American Academy of Child and Adolescent Psychiatry showing that individuals with the dopamine receptor D4 and dopamine transporter genotypes believed to confer lower susceptibility to ADHD had greater improvement in their hyperactive-impulsive symptoms with methylphenidate treatment than those with the “high risk” genetic variants. She also coauthored a study on a novel genotyping assay for carboxylesterase 1 (CES1), the enzyme which metabolizes methylphenidate, and is currently undertaking a study on CES1 genetic variants’ effects on methylphenidate response.
Dr. Froehlich also enhances care for children with ADHD through teaching and other professional activities. She has served as an invited speaker providing seminars for professionals and workshops for families in international, national, and regional forums. Currently, Dr. Froehlich co-chairs the Society for Developmental and Behavioral Pediatrics ADHD Special Interest Group, and coordinates ADHD-related projects and educational seminars for the Society membership in this capacity.
BA: East Asian Studies, Columbia University, 1992.
MD: Yale University School of Medicine, 1999.
MS: Epidemiology, University of Cincinnati, 2007.
Pediatric Intern: Children’s Hospital of Philadelphia, 1999-2000.
Pediatric Resident: Children’s Hospital of Philadelphia, 2000-2002.
Fellowship: Developmental and Behavioral Pediatrics, Cincinnati Children’s Hospital, 2002-2005; General Pediatrics National Research Service Award Fellow, Cincinnati Children’s Hospital, 2004-2007.
Zhu HJ, Brinda B, Froehlich TE, Markowitz JS. A Discriminative Analytical Method for Detection of CES1A1 and CES1A2/CES1A3 Genetic Variants. Pharmacogenetics and Genomics. 2012; 22(3): 215-218.
Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS. Pharmacogenetic Predictors of Methylphenidate Dose-Response in Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2011;11:1129-1139.
Froehlich TE, Anixt J, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman R. Update on Environmental Risk Factors for Attention-Deficit/Hyperactivity Disorder. Current Psychiatry Reports. 2011;13(5):333-44.
Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M. Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Neuropsychopharmacology. 2011; 36(5): 1060-1072.
Langberg JM, Vaughn AJ, Brinkman WB, Froehlich T, Epstein, JN. Clinical utility of the Vanderbilt ADHD rating scale for identifying children without comorbid learning disorders. Pediatrics. 2010; 126: e1033-e1038.
Froehlich TE, McGough JJ, Stein MA. Progress and Promise of ADHD Pharmacogenetics. CNS Drugs. 2010; 24: 99-117.
Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, Kahn RS. The Association of Tobacco and Lead Exposure with Attention-Deficit/Hyperactivity Disorder in a National Sample of U.S. Children. Pediatrics. 2009; 124: e1054-63.
Langberg JM, Froehlich TE, Loren RE, Martin JE, Epstein JN. Assessing Children with ADHD in Primary Care Settings. Expert Review of Neurotherapeutics. 2008; 8: 627-41.
Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence and Treatment of ADHD in a National Sample of U.S. Children. Archives of Pediatrics and Adolescent Medicine. 2007;161(9): 857-864.
Froehlich TE, Lanphear BP, Dietrich KN, Cory-Slechta DA, Wang N, Kahn RS. Interactive Effects of a DRD4 Polymorphism, Lead, and Sex on Executive Functions in Children. Biological Psychiatry. 2007; 62: 243-249.
Medication Response in Children with Predominantly Inattentive Type ADHD. Principal Investigator. National Institute of Mental Health Career Development (K23). 2009-2014.
Mechanisms of Pesticide-Induced Neurobehavioral Deficits: Relevance to ADHD. Co-Investigator. National Institute of Environmental Health Sciences (R01). 2010-2013.
Richard C. Gilman, PhD Psychologist, Division of Child and Adolescent Psychiatry
Psychologist, Division of Child and Adolescent Psychiatry
Professor, UC Department of Pediatrics
Depression; anxiety; adjustment issues; learning issues
PhD: University of South Carolina, Columbia, SC.
Fellowship: Georgia State University Counseling Center, Atlanta, GA.
Residency: Father Flanagan’s Boy’s Home (aka Boy’s Town), Boys Town, NE.
Bowker JC, Adams RE, Fredstrom B, Gilman R. Experiences of being ignored by peers during late adolescence: Linkages to psychological adjustment. Merrill-Palmer Quarterly. 2013. Epub ahead of print.
Deckman T, DeWall N, Way B, Gilman R, Richman S. Can Marijuana reduce social pain?Social Psychological and Personality Science. 2013. Epub ahead of print.
Gilman R, Chard K, Schumm J. Hope as a change mechanism in the treatment of post-traumatic stress disorder among veterans. Psychological Trauma: Theory, Research, Practice and Policy. 2012 May;4(3):270-277.
Gilman R, Carter-Sowell A, DeWall N, Adams R, Carboni I. Validation of the Ostracism Experiences Scale for adolescents. Psychological Assessment. 2013;25(2): 319-330.
Carboni I, Gilman R. Brokers at risk: Gender differences in the effects of structural position on social stress and life satisfaction. Group Dynamics. 2012 Sep;16(3):218-230.
DeWall CN, Gilman R, Shariff V, Carboni I, Rice KG. Left out, sluggardly, and blue: Low self-control mediates the relationship between ostracism and depression. Personality and Individual Differences. 2012;16:218-230.
Fredstrom B, Adams R, Gilman R. Distinct correlates related to on-line versus in-person peer victimization among adolescents. Journal of Youth and Adolescence. 2011;40:405-415.
Froehlich TE, Anixt J, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman R. Update on environmental risk factors for attention-deficit/hyperactivity disorder. Current Psychiatry Reports. 2011;13:333-344.
Gilman R, Adams R, Nounopolous A. The interpersonal relationships and social perceptions of adolescent perfectionists. Journal of Research in Adolescence. 2011;21:505-511.
Rice K, Ashby J, Gilman R. Classifying adolescent perfectionists. Psychological Assessment. 2011;23:583-577.
Using SNA to Examine the Long-Term Outcomes of Socially Excluded Adolescents. Principal Investigator. NICHD. April 2012-March, 2014.
Validating a program to enhance social learning and preventing early sexual activity among children in a high-risk setting. Co-Investigator. NIH/NICHD. Jan. 2007- Jan. 2009.
Self-Management of Type 1 Diabetes During Adolescence. NIDDK. Consultant. 201
Patricia Manning-Courtney, MD Co-Director, Division of Developmental and Behavioral Pediatrics
Co-Director, Division of Developmental and Behavioral Pediatrics
Director, Kelly O'Leary Center
Susan E. Wiley, MD Co-Director, Division of Developmental and Behavioral Medicine
Co-Director, Division of Developmental and Behavioral Medicine
Pediatrician, Division of Developmental and Behavioral Pediatrics
UC Department of Pediatrics
Adjunct Associate Professor
Sensory loss (deaf, hard of hearing, blind, low vision)
Deafness associated with an additional disability
MD: University of Cincinnati, OH, 1994.
Residency: Pediatrics, Children's Hospital Medical Center of Cincinnati, OH.
Fellowship: Developmental Pediatrics, Cincinnati Center for Developmental Disorders, Cincinnati, OH.
Certification: Pediatrics, 1997.
Certification: Developmental-Behavioral Pediatrics, 2002.
Meinzen-Derr J, Wiley S, Grether S, Choo DI. Children with cochlear implants and developmental disabilities: A language skills study with developmentally matched hearing peers. Res Dev Disabil. 2010 Dec 1.
Meinzen-Derr J, Wiley S, Grether S, Choo DI. Language performance in children with cochlear implants and additional disabilities. Laryngoscope. 2010 Feb;120(2):405-13. Wiley S, Meinzen-Derr J. Access to cochlear implant candidacy evaluations: who is not making it to the team evaluations? Int J Audiol. 2009 Feb;48(2):74-9. Wiley S, Meinzen-Derr J, Choo D. Auditory skills development among children with developmental delays and cochlear implants. Ann Otol Rhinol Laryngol. 2008 Oct;117(10):711-8.
Meinzen-Derr J, Lim LH, Choo DI, Buyniski S, Wiley S. Pediatric hearing impairment caregiver experience: impact of duration of hearing loss on parental stress. Int J Pediatr Otorhinolaryngol. 2008 Nov;72(11):1693-703. Meinzen-Derr J, Wiley S, Creighton J, Choo D. Auditory Skills Checklist: clinical tool for monitoring functional auditory skill development in young children with cochlear implants. Ann Otol Rhinol Laryngol. 2007 Nov;116(11):812-8. Wiley S, Choo D, Meinzen-Derr J, Hilbert L, Greinwald J. GJB2 mutations and additional disabilities in a pediatric cochlear implant population. Int J Pediatr Otorhinolaryngol. 2006 Mar;70(3):493-500.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center